CytoDyn Inc. — Form D

CytoDyn Inc. of VANCOUVER, WA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-11. The offering totals $18.6M, of which $18.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (102)

Showing 25 of 102 people.

NameRoleLocation
Tyler BlokRelated PersonVancouver, WA
Karen J. Brunke, Ph.D.Related PersonVancouver, WA
Ryan M. DunlapRelated PersonVancouver, WA
Robert E. HoffmanRelated PersonVancouver, WA
Jacob P. LalezariRelated PersonVancouver, WA
Lishomwa C. Ndhlovu, M.D., Ph.D.Related PersonVancouver, WA
Stephen M. SimesRelated PersonVancouver, WA
Tanya D. UrbachRelated PersonVancouver, WA
Michael A KlumpDirectorAtlanta, GA
Richard G PestellDirectorWynnewood, PA
Richard G PestellExecutive OfficerWynnewood, PA
Ryan G DunlapDirectorVancouver, WA
Arvin Cyrus ArmanExecutive OfficerVancouver, WA
Karen J BrunkeDirectorVancouver, WA
Antonio Durkee MigliareseExecutive OfficerVancouver, WA
Lishomwa C NdhlovuDirectorVancouver, WA
Tanya Durkee UrbachDirectorVancouver, WA
Nitya G RayExecutive OfficerVancouver, WA
Antonio G MigliareseExecutive OfficerVancouver, WA
Christopher G RecknorExecutive OfficerVancouver, WA
Harish Z SeethamrajuDirectorVancouver, WA
Scott A Kelly, M.D.DirectorVancouver, WA
Scott A Kelly, M.D.Executive OfficerVancouver, WA
Nitya G Ray, Ph.D.Executive OfficerVancouver, WA
Nader Z Pourhassan, Ph.D.DirectorVancouver, WA

Other filings by this issuer (31)

Showing 15 of 31 filings.

FiledFormOfferingSold
2022-09-19D/A$21.8M$21.8M
2022-04-25D/A$1.9M
2022-04-22D$1.9M
2021-12-03D$53.6M$11.4M
2021-09-16D$25.2M$2.9M
2020-12-16D$1.2M
2020-12-16D$1.0M$1.0M
2020-04-07D/A$11.4M$7.6M
2020-03-30D$1.2M$882K
2020-02-14D$7.6M$7.6M
2019-11-12D/A$20.0M$7.8M
2019-04-02D$5.0M$3.2M
2018-09-10D$25.0M$13.2M
2018-02-28D/A$17.6M$17.6M
2017-11-16D$15.0M$1.2M

More